A Phase 3 Randomized, Placebo-controlled, Double-blind Study of JNJ-56021927 Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects with Low-volume Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Disease (cancer type)

Prostate Cancer

Contact information

  • Florida West Coast-Fort Myers: Lauren Embry (239) 344-2232

Patient Selection Criteria

Prostate cancer with distant metastatic disease

Research sponsor

Janssen Research & Development

Reference ID#

Janssen 3002

State(s)

  • Florida

Linked Physicians

Back
To top